1. Development of dissolution screening 5; 2. Theory of dissolution 11; 3. Theoretical principles for the release of a drug from dose types 37; 4. Impact of the physicochemical residential or commercial properties of the drug on dissolution rate 53; 5.
Factors impacting the rate of dissolution of strong dose kinds 73; 6. Results of storage and product packaging on the dissolution of drug solutions 107; 7. Elements associating with the dissolution device 115; 8.
Effect of the test specifications on dissolution rate 145; 9. Dissolution of suspensions 173;10 Dissolution of topical dose types (creams, gels, and lotions) 189;11 Dissolutions of suppositories 205; 12.
Dissolution qualities of controlled-release systems 215;13 Approaches for improvement of the drug-dissolution qualities 265;14 Establishing a brand-new dissolution approach 285;15 Bioavailability, meanings and historic point of view 297; 17.
In vitro modeling for drug absorption 315;18 Pharmacokinetic factors to consider in bioavailability research studies 335;19 Bioavailability and variations in drug blood levels 367;20 Bioavailability and the biologic action 385; 21.
Measurements of bioavailability 399;22 General problems to be thought about in carrying out bioavailability research studies 415;23 Bioavailability of controlled-release dose types 425;24 In vivo release and bioavailability of topical preparations 437; 25.
Methods for improvement of bioavailability 455;26 Bioequivalence: basic meanings 477;27 Bioequivalence: medical history 481;28 Connection of in vitro rate of dissolution with in vivo bioavailability 491; 29.
Determination of bioequivalence and its regulative elements 517;30 The main bioequivalence procedures and restorative equivalence 533.
http://pharmacytechprogram.com/dissolution-bioavailability-bioequivalence/
No comments:
Post a Comment